ACIU — AC Immune AG Share News
0.000.00%
Last trade - 00:00- $249.35m
- $163.15m
- CH₣3.57m
Brief: Ac Immune Progress Update On Phase 2 Active Immunotherapy Clinical Pipeline
Brief: AC Immune Priced An Underwritten Offering Of 14.3 Million Of Shares At $3.50 Per Share
Brief: AC Immune’s Targeted Anti-pTau Active Immunotherapy For Alzheimer’s Disease Advances Into Phase 2B Trial
Focus: Researchers return to Alzheimer's vaccines, buoyed by recent drug success
AC Immune SA reports results for the quarter ended in September - Earnings Summary
Brief: AC Immune Q3 EPS CHF -0.18
AC Immune SA expected to post earnings of 3 rappen a share - Earnings Preview
AC Immune SA reports results for the quarter ended in June - Earnings Summary
Brief: AC Immune Appoints New Chief Medical Officer
AC Immune SA expected to post a loss of 20 rappen a share - Earnings Preview
Factbox: Companies in Alzheimer's race after US nod for Eisai/Biogen drug
AC Immune up on FDA's 'fast-track' tag for Alzheimer's disease therapy
Brief: AC Immune Receives FDA Fast Track Designation For Anti-Amyloid-Beta Active Immunotherapy, ACI-24.060 To Treat Alzheimer’S Disease
Brief: AC Immune Reports First Quarter 2023 Financial Results
AC Immune SA expected to post a loss of 23 rappen a share - Earnings Preview
AC Immune SA reports results for the quarter ended in December - Earnings Summary
Brief: AC Immune Reports Full Year 2022 Financial Results And Provides Corporate Update
AC Immune SA expected to post a loss of 25 rappen a share - Earnings Preview
Brief: AC Immune Awarded New Grants From Mjff And Target Als Supporting Programs Targeting Tdp-43